1. ¹II Department of Pathology, University of Milan School of Medicine, Milan, Italy
2. ²San Paolo Hospital, University of Milan School of Medicine at Humanitas Clinical Institute, Milan, Italy
3. ³IRCCS Ospedale Maggiore, University of Milan School of Medicine at Humanitas Clinical Institute, Milan, Italy
4. ⁴Department of Pathology, University of Milan School of Medicine at Humanitas Clinical Institute, Milan, Italy
5. ⁵Department of Clinical Surgery, University of Milan School of Medicine, Milan, Italy
6. ⁶Centro Interuniversitario di Ricerche Oncologiche, Milan, Italy

Correspondence: Dr. Solange Romagnoli, II Department of Pathology, University of Milan School of Medicine, Via A di Rudinì 8, 20142 Milano, Italy. E-mail: solange.romagnoli@unimi.it

Received 22 November 2000.

Abstract

Alterations in proto-oncogenes and tumor suppressor genes play a role in the sequence from Barrett's metaplasia to esophageal adenocarcinoma. The present study aims to ascertain whether molecular abnormalities take place in Barrett's metaplasia and low-grade dysplasia and to correlate them with the histological features of the esophageal mucosa. Forty-one formalin-fixed, paraffin-embedded endoscopic esophageal biopsies were classified according to the type of metaplastic changes (noncolumnar fundic and cardial metaplasia; columnar metaplasia, with and without intestinal features). After microdissection samples were examined for loss of heterozygosity (LOH) using polymorphic markers on 5q (D5S82), corresponding to APC (adenomatous polyposis coli) gene, 13q (CA repeat in intron 2 position 14815 to 14998 of the retinoblastoma gene), 17p (D17S513) corresponding to p53 locus, and for p53 mutations. Molecular alterations including LOH, allelic imbalance, and microsatellite instability could be detected in all types of metaplastic changes and sporadically in the squamous epithelium adjacent to the metaplastic tissue. Molecular alterations involving microsatellites D5S82 and the CA repeat inside the retinoblastoma gene were more frequent in nonintestinal metaplasia whereas those involving the p53 locus took place in columnar intestinal metaplasia and in low-grade dysplasia. Clonal changes were demonstrated in different metaplastic areas in three patients. Genetic alterations comprising LOH and microsatellite instability characterize Barrett's mucosa and appear related to the type of metaplastic change. Some of them precede the development of intestinal metaplasia, suggesting that genetic alterations take place earlier than previously thought.